对大鼠压疮缺血- 再灌注损伤模型构建及应用的思考

目的:为构建大鼠压疮缺血-再灌注损伤模型提供简易模型装置及有效的造模方法。方法:自制简易压疮缺血-再灌注损伤模型装置,对120只雌性大鼠腿部近膝关节骨隆突处进行为期3日的压疮造模,5个循环/日,每个循环分别实现120 min的缺血期及30 min的再灌注期,分别于造模第1 d、2 d、3 d及造模结束第1 d观察大鼠病灶创面的颜色、形态、水肿、结痂、渗出以及大鼠行为学状况、并于造模结束第1 d统计存活率及成模率。结果:造模第1 d,Ⅰ期压疮100只,Ⅱ期压疮17只,死亡3只;造模第2 d,Ⅰ期压疮26只,Ⅱ期压疮84只,死亡7只;造模第3 d,Ⅰ期压疮11只,Ⅱ期压疮95只,死亡4只;造模结束第1 d,Ⅰ期压疮5只,Ⅱ期压疮101只,死亡0只。120只实验大鼠,共14只大鼠死亡,造模存活率达88.33%,Ⅱ期压疮造模成功率达84.17%。结论:本造模装置可有效制备大鼠压疮缺血-再灌注动物模型,具有接近临床,操作简便,无需麻醉,Ⅱ期压疮成模率较高、避免铁片植入带来的皮肤负损伤等优势,这将为皮肤压疮、乃至慢性损伤组织的机制研究、修复及愈合相关研究提供重要理论和实验依据。     

三级质控体系预防压疮的临床研究

目的:探讨三级质控体系在预防压疮中的作用,有效控制压疮发生。方法:通过成立压疮护理三级质控体系即基层压疮护理小组、医院压疮管理小组及护理部压疮质控小组,改进压疮管理流程,强化护理人员专项技能,有效实施基础护理,从根本上预防压疮发生。结果:难免压疮发生率明显下降,患者对护理服务满意度提高。结论:三级质控体系能有效控制压疮发生,促进原发疾病痊愈,减轻患者经济负担,提高医院社会效益。     

艾灸治疗压疮的研究现状

艾灸能够发挥温经散寒、行气活血通经活络散瘀通滞的作用,治疗压疮的临床疗效显著,但其分子机制仍不清楚。新血管的生成在压疮修复、愈合的过程中发挥重要的作用,可为新生组织提供着氧气和营养成分。虽然现代医学对褥疮组织的血管新生分子机制研究不断深入,但仍缺乏有效的治疗手段。艾条的种类、施灸操作种类及艾灸的作用机理等方面均可影响艾灸治疗压疮的疗效。如何将艾灸治疗褥疮的中医原创特色与现代医学对于新生血管深入的分子机制研究有机结合是值得思考的问题。     

应用分子定向进化技术适时检测及预防鳗鱼主要疾病的初步探讨

应用分子定向进化(directedmolecularevolution)技术研究和解决复杂的生物学和化学问题,已成为化学和生物学中最活跃的领域之一。针对目前鳗鱼主要疾病的检测及预防现状和出现的技术难点及不足,初步探讨了分子定向进化技术在这方面的应用及前景。     

Radiation Processed Amniotic Membranes in the Treatment of Non-Healing Ulcers of Different Etiologies

The amniotic membranes were collected from the placentae of selected and screened donors. Processing was done by washing the fresh amniotic membrane successively in sterile saline, 0.05% sodium hypochlorite solution and sterile distilled water until it was completely cleared of blood particles. The membranes were sterilized by gamma irradiation at 25 kGy. The processed amniotic membranes were applied to 50 open wounds comprising of 42 full thickness defects and eight partial thickness defects. These included leprotic, diabetic, traumatic, gravitational ulcers and superficial burn in the form of scald and corrosive burn. The radiation processed amniotic membranes favoured healing of unresponsive and non-healing ulcers of different etiologies. Ulcers with duration of minimum 3 weeks to maximum 12 months were found to heal in 2-6 weeks by the application of amniotic membranes.     

埃博拉病毒检测与防治技术在中国的专利申请状况分析

近年来,埃博拉病毒(EBOV)因其在非洲造成的严峻疫情而引起了广泛关注。本文对涉及埃博拉病毒检测与防治技术方面的在中国申请的国内外专利申请数量、年代分布、技术发展状况等信息进行分析,对国内埃博拉病毒检测、免疫、治疗相关专利技术进行简要总结,并对目前热点关注药物(jk-05,ZMapp,VSV-EBOV)专利申请信息进行比较概括,结果表明,我国申请人在提出的相关专利申请数量以及技术多样性上与国外申请人存在差距,为国内科研人员提供了相关技术领域参考。     

激光联合紫外线治疗II 期、III期压疮患者的疗效观察

目的：研究激光联合紫外线治疗II期和III期压疮患者的疗效。方法：回顾性分析2010 年7 月至2014 年7 月我科收治的59 例II期和III 期压疮患者的临床资料,按照护理方式的不同分为对照组（30 例）和联合组（29 例）,对照组在基础治疗的基础上进 行传统护理,联合组在基础治疗的基础上加用激光联合紫外线护理,两组治疗14 天后,采用压疮愈合评估量表（PUSH）评分比较 两组疗效。结果：两组患者治疗后PUSH评分均降低,且联合组降低幅度显著高于对照组,差异均有统计学意义（P<0.001）。结论： 激光联合紫外线治疗对II期和III期压疮患者的恢复具有显著促进作用,值得推广使用。     

红曲中桔霉素的检测及控制

红曲是指以大米为原料,用红曲菌属（Monascusspp．）红曲霉发酵培养制得,具有红色的颗粒或用其制成的粉末。目前红曲可分为色曲、酒曲和功能性红曲。在红曲霉的发酵过程中,同时与红曲色素相伴产生一种有害的次级代谢产物一桔霉素。研究表明桔霉素具有肾毒性,可致畸、致癌和诱发基因突变。桔霉素的存在,制约了红曲在食品及药品方面的广泛应用,在一定程度上阻碍了红曲产业的发展。为此,在红曲生产中如何快速准确检测桔霉素以及有效地防控桔霉素,是我们当前迫切需要解决的问题。本文对近年来国内外红曲中桔霉素的检测方法及控制策略进展进行了综述。目前,桔霉素的检测方法主要有抑菌圈法、TLC法、酶联免疫法和HPLC法等,其中HPLC法是检测红曲中桔霉素高效且应用最广泛的方法。桔霉素的控制主要从菌种选育,发酵工艺及产品后续处理等方面进行调控。目前尚没有成熟的控制策略全部去除桔霉素,只有采用低产桔霉素的菌种,适合的生产工艺及结合后续的物理或化学处理等综合措施,生产出符合桔霉素控制标准的高品质红曲产品。     

Alterations in Membrane Potential in Mitochondria Isolated from Brain Subregions During Focal Cerebral Ischemia and Early Reperfusion: Evaluation Using Flow Cytometry

Mitochondria isolated from brain tissue following middle cerebral artery occlusion or during early reperfusion were tested for their ability to generate a membrane potential under standard conditions in vitro. Membrane potential was evaluated based on rhodamine 123 fluorescence in the mitochondria as detected using flow cytometry. Compared with equivalent samples from the contralateral hemisphere, the geometric mean fluorescence was significantly lower in mitochondria prepared from the striatum and perifocal tissue in the cortex at 3 h ischemia. During reperfusion, this property was decreased in mitochondria from tissue in the striatum and cortex that had been part of severely ischemic core tissue during the arterial occlusion. These findings provide additional evidence that mitochondria develop changes during ischemia and reperfusion that are likely to limit their ability to respond to changing energy requirements and contribute to cell dysfunction and cell death. It also demonstrates the ability to gain a sensitive measure of these mitochondrial changes using flow cytometry.     

Effect of Reperfusion Following Cerebral Ischaemia on the Activity of the Mitochondrial Respiratory Chain in the Gerbil Brain

Abstract: The effect of reperfusion following 30 min of cerebral ischaemia on brain mitochondrial respiratory chain activity has been studied in the gerbil. The state 3 respiration rates with both FAD- and NAD-linked substrates were reduced after ischaemia. After 5 min of reperfusion, state 3 respiration with FAD-linked substrates was restored, but levels of NAD-linked substrates did not return to control values until 30 min of reperfusion. By 120 min of reperfusion state 3 respiration decreased relative to control values with all substrates studied. Measurement of the individual respiratory chain complexes showed that complex I, complex II–III, and complex V activities were reduced after ischaemia. By 5 min of reperfusion complex II–III activity was restored, but the activities of complexes I and V did not return to control values until 30 min of reperfusion. In contrast, complex IV activity was unaffected by ischaemia or 5 and 30 min of reperfusion but was significantly reduced after 120 min of reperfusion, possibly owing to free radical production and lipid peroxidation.     

细胞因子在心肌缺血再灌注损伤中的作用机制

心肌缺血再灌注损伤(Myocardial Ischemic/Reperfusion Injury,MI/RI)已成为临床心肌梗塞病人血管再通后重要的死亡因素之一,对于这一过程中因细胞因子诱导炎症反应的的作用机制仍是目前研究的热点。本文综述了与MI/RI相关的细胞因子的作用及其机制,并就其相互作用进行探讨。     

热休克蛋白质70对大鼠肝脏缺血再灌注后NOS活力的影响

目的为探讨热应激预处理对肝脏缺血再灌注损伤的保护作用的机制,采用局部热应激处理诱导热休克蛋白质(HSP70)的表达,检测了HSP70对肝脏缺血再灌注时NOS活力的影响。方法将实验大鼠随机分为热应激预处理组与非预处理组,对比观察两组动物肝脏缺血再灌注后0、4、8、12、24h期间内肝脏HSP70的表达、NOS活力及血清乳酸脱氢酶(lactate dehydrogenase,LDH)的活性与肝脏组织学改变。结果热应激预处理组HSP70的表达水平均比非预处理组同一时间点高,而NOS活力及血清LDH的活性较非预处理组低。与非预处理组比较,经热应激预处理肝组织损伤较轻。结论热应激预处理诱导产生的热休克蛋白70保护肝脏缺血再灌注损伤的作用途径之一可能是通过抑制NO的产生,从而降低大量自由基对肝脏的损害。     

实验用小型猪呼吸道支原体检测及方法比较

目的通过常用的三种不同方法对支原体的检测,了解实验用小型猪支原体感染情况,为今后实验用小型猪支原体检测方法国家标准的制定提供参考。方法采用培养法、PCR和ELISA方法分别对20头小型猪的气管、肺和血清进行检测。结果三种检测方法中,PCR方法支原体阳性检出率为15%,ELISA方法为20%,而培养法结果均为阴性。结论目前在普通级小型猪中存在支原体的感染。检测方法中PCR和ELISA方法较培养法更省时,敏感性更高。     

急性缺血心肌炎症与再灌注

近20年来,随着经皮冠状动脉介入(percutaneous coronary intervention,PCI)治疗的发展,相关的研究日益增多,许多研究显示炎症反应在行PCI治疗的患者的预后中发挥着很大的作用。PCI术后患者心肌再灌注的疗效日益引起人们的关注,尤其是再灌注无复流的危害和重要性,如何控制炎症因子(如hs-CRP,IL-6,TNF-α等)的水平,以有益于行PCI术的患者,需要更多一些前瞻性研究去观察。     

Suppression of LRRC19 promotes cutaneous wound healing in pressure ulcers in mice

The ischemia-reperfusion (I/R) induced skin lesion has been identified as primary cause of pressure ulcer. Better understanding of the mechanism is required for new therapy development. Leucine rich repeat containing protein 19 (LRRC19) is a recently discovered transmembrane protein containing leucine-rich repeats and plays a role in immune response. To investigate the role of LRRC19 in pressure ulcers, mouse ulcer model was established with two cycles of I/R. The expression of LRRC19 was assessed during injury. siRNA mediated LRRC19 downregulation was applied to investigate the disease severity, immune cell infiltration and pro-inflammatory cytokines production. The primary skin fibroblasts were stimulated with IL-1β to dissect the molecular mechanism. LRRC19 was readily induced in I/R induced lesion site in a pattern mimicking the disease progress as measured by wound area. Knockdown of LRRC19 by siRNA significantly alleviated the disease severity and attenuated immune cell infiltration and pro-inflammatory cytokines production. In primary skin fibroblast model, siRNA knockdown of LRRC19 suppressed IL-1β mediated NFκB activation and its downstream cytokines production. LRRC19 was a novel factor for I/R-induced tissue damage by promoting NFκB dependent pro-inflammatory response. Our results supported that LRRC19 could be a potential therapeutic target for pressure ulcers.     

Beneficial Effects of Poly (ADP-ribose) Polymerase Inhibition Against the Reperfusion Injury in Heart Transplantation

We investigated the effect of 3-aminobenzamide (3-AB), an inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP), against early ischemia/reperfusion (IR) injury in heart transplantation. In our experimental model, rat heart subjected to heterotopic transplantation, low temperature global ischemia (2 h) was followed by an in vivo reperfusion (60 min). In these conditions, and in the absence of 3-AB treatment, clear signs of oxidative stress, such as lipid peroxidation, increase in protein carbonyls and DNA strand breaks, were evident; PARP was markedly activated in concomitance with a significant NAD + and ATP depletion. The results of microscopic observations (nuclear clearings, plasma membrane discontinuity), and the observed rise in the serum levels of heart damage markers, suggested the development of necrotic processes while, conversely, no typical sign of apoptosis was evident. Compared to the effects observed in untreated IR heart, the administration of 3-AB (10 mg/kg to the donor and to the recipient animal), but not that of its inactive analogue 3-aminobenzoic acid, significantly modified the above parameters: the levels of oxidative stress markers were significantly reduced; PARP activation was markedly inhibited and this matched a significant rise in NAD + and ATP levels. PARP inhibition also caused a reduced release of the cardiospecific damage markers and attenuated morphological cardiomyocyte alterations, save that, in this condition, we noted the appearance of typical apoptotic markers: activation of caspase-3, oligonucleosomal DNA fragmentation, ISEL positive nuclei. Possible mechanisms for these effects are discussed, in any case the present results indicate that PARP inhibition has an overall beneficial effect against myocardial reperfusion injury, mainly due to prevention of energy depletion. In this context, the signs of apoptosis observed under 3-AB treatment might be ascribed to the maintenance of sufficient intracellular energy levels. These latter allow irreversible damages triggered during the ischemic phase to proceed towards apoptosis instead of towards necrosis, as it appears to happen when the energetic pools are depleted by high PARP activity.     

两种压疮评估量表在骨科患者中的应用研究

目的:比较分析Waterlow和Norton两种压疮评估量表在预测骨折患者压疮中的临床效果。方法:选取某院骨科患者186例,由2名临床护士分别用2种量表对患者进行皮肤评估和量表评分,两者分别独立进行,比较分析两种量表对患者压疮的预测效果。结果:患者共发生压疮5例,发生率为2.69%(5/186);Waterlow量表和Norton量表的临界预测值分别为17分和14分;而二者的受试者工作特征曲线(Receiver Operator Curve,ROC)下面积分别为0.647和0.439。结论:Waterlow量表包含了与骨科疾病相关的压疮危险因素,更加适用于预测骨科患者压疮,但仍需要做进一步改进。     

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration

Renal ischaemia reperfusion injury (IRI) is a common cause of acute kidney injury (AKI) in patients and occlusion of renal blood flow is unavoidable during renal transplantation. Experimental models that accurately and reproducibly recapitulate renal IRI are crucial in dissecting the pathophysiology of AKI and the development of novel therapeutic agents. Presented here is a mouse model of renal IRI that results in reproducible AKI. This is achieved by a midline laparotomy approach for the surgery with one incision allowing both a right nephrectomy that provides control tissue and clamping of the left renal pedicle to induce ischaemia of the left kidney. By careful monitoring of the clamp position and body temperature during the period of ischaemia this model achieves reproducible functional and structural injury. Mice sacrificed 24 hr following surgery demonstrate loss of renal function with elevation of the serum or plasma creatinine level as well as structural kidney damage with acute tubular necrosis evident. Renal function improves and the acute tissue injury resolves during the course of 7 days following renal IRI such that this model may be used to study renal regeneration. This model of renal IRI has been utilized to study the molecular and cellular pathophysiology of AKI as well as analysis of the subsequent renal regeneration.     

一次性可调压限压式灌肠器的实验研究

目的：研究一次性可调压限压式灌肠器的性能。方法：建立模型,测定模拟体内环境下灌肠治疗时肠管各点的压力和灌肠器可调压限压阀开启时的压力是否一致。结果：测定模拟肠管各点压力与灌肠器的可调压限压阀开启时压力一致。结论：一次性可调压限压式灌肠器的性能达到设计要求,操作简便,具有科学性、稳定性、安全性,值得推广。     

依达拉奉对犬自体肾移植缺血再灌注损伤的保护作用研究

目的：探讨依达拉奉对犬自体肾移植缺血再灌注损伤的影响及机制。方法：将18 只体重匹配的健康杂种犬随机分为假手术组（S组）、依达拉奉组（ED组）、生理盐水组（PS 组）,每组各6只。S 组仅进行肾手术切除;ED组在阻断前在供体静脉内注入依达拉奉10 mg/kg,然后使用200 mL加入依达拉奉10 mg/kg 的UW液灌洗供体肾并在同样的保存液中保存供体肾8 小时,且再灌注开始时立即在受体静脉内给予依达拉奉10 mg/kg;PS 组同法使用相同体积的生理盐水。再灌注4 h 后检测MDA、MPO、SOD、iNOS、eNOS等活性;术后24 h 检测血清肌酐（Cr）、尿素氮（BUN）浓度;光镜下观察肾组织病理学改变。结果：PS 组MDA显著高于S 组及ED组（P〈0.05）,PS组MPO 含量亦低于S 组及ED组（P〈0.05）。PS组SOD、eNOS 含量显著低于于S组及ED组（P〈0.05）,PS 组iNOS含量高于S 组及ED 组（P〈0.05）,ED组的肾损伤明显减轻。结论：依达拉奉能减轻肾移植缺血再灌注损伤,其机制可能与减轻肾脂质过氧化反应有关。